Skip to main content
. 2016 Oct 11;6:34710. doi: 10.1038/srep34710

Figure 4. IND concentrations in the maternal uterus and fetus.

Figure 4

To assess the shift in biodistribution in different formulations, IND was administered either in free form or within LIP-IND-ORA. IND concentrations in the maternal uterus and fetus were determined by LC-MS/MS analysis. Mean ± SEM, n = 6. **p-value < 0.01 to the levels of IND when the drug was administered via LIP-IND-ORA.